Characterization of a superantigen produced by Yersinia pseudotuberculosis

Preparative Biochemistry and Biotechnology

Volumn 27, Issue 2-3, 1997, Pages 173-208

  Abe, Jun ^a   Takeda, Tae ^a  

^a NATIONAL CHILDREN S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); YERSINIA PSEUDOTUBERCULOSIS;

EID: 0031147641     PISSN: 10826068     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826069708000075     Document Type: Review

References (159)

1. Knapp W. Mesenteric adenitis due to Pasteurella pseudotuberculosis in young people. N Engl J Med 1958; 259:776-778.
2. Winblad S, Nillehn B, Sternby NH. Yersinia enterocolitica (Pasteurella X) in human enteric infections. Br Med J 1966; 2:1363-1366.
3. Krober MS, Bass JW, Barcia PJ. Scarlatiniform rash and pleural effusion in a patient with Yersinia pseudotuberculosis infection. J Pediatr 1983; 102:879-881.
4. Leino R, Makela AL, Tiilikainen A, et al. Yersinia athritis in children. Scand J Rheumatol 1980; 9:245-249.
5. Tertti R, Granfors K, Lehtonen OP, et al. An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis 1984; 149:245-250.
6. Saari KM, Maki M, Paivonsalo T, et al. Acute anterior uveitis and conjunctivitis following Yersinia infection in children. Int Ophthalmol 1986; 9:237-241.
7. Baba K, Takeda N, Tanaka M. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease. Contrib Microbiol Immunol 1991; 12:292-296.
8. Davenport A, O'Connor B, Finn R. Acute renal failure following Yersinia pseudotuberculosis septicaemia. Postgrad Med J 1987; 63:815-6.
9. Une T. Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolotica and Y. pseudotuberculosis. Microbiol Immunol 1977; 21:505-516.
10. El MN, Mair NS. The histopathology of enteric infection with Yersinia pseudotuberculosis. Am J Clin Pathol 1979; 71:631-639.
11. Cornelis G, Laroche Y, Ballingand G, et al. Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infec Dis 1987; 9:64-87.
12. Brubaker RR. Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev 1991; 4:309-324.
13. Salyers AA, Whitt DD. Yersinia infection. In: Salyers AA, Whitt DD, eds. Bacterial pathogenesis, a molecular approach, Washington, DC: ASM Press, 1994:213-228.
14. Bolin, I, Norlander L, Wolf WH. Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect Immun 1982; 37:506-512.
15. Portnoy DA, Wolf WH, Bolin I, et al. Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun 1984; 43:108-114.
16. Stuart PM, Woodward JG. Yersinia enterocolitica produces superantigenic activity. J Immunol 1992; 148:225-233.
17. Abe I, Takeda T, Watanabe Y, et al. Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol 1993; 151:4183-4188.
18. Uchiyama T, Miyoshi AT, Kato H, et al. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol 1993; 151:4407-4413.
19. Ito Y, Abe J, Yoshino K, et al. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J Immunol 1995; 154:5896-5906.
20. Miyoshi AT, Abe A, Kato H, et al. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J Immunol 1995; 154:5228-5234.
21. Simonet M, Richard S, Berche P. Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect Immun 1990; 58:841-845.
22. Tertti R, Eerola E, Lehtonen OP, et al. Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol 1987; 68:266-274.
23. Rosqvist R, Bolin I, Wolf WH. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect Immun 1988; 56:2139-2143.
24. Weber J, Finlayson NB, Mark JB. Mesenteric lymphadenitis and terminal ileitis due to Yersinia pseudotuberculosis. N Engl J Med 1970; 283:172-174.
25. Saari TN, Triplett DA. Yersinia pseudotuberculosis mesenteric adenitis. J Pediatr 1974; 85:656-659.
26. Paterson IC, Grant IW., Crompton GK. Terminal ileitis due to Yersinia pseudotuberculosis. Br Med J 1976; 2:6041.
27. Zink DL, Feeley JC, Wells JG, et al. Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature 1980; 283:224-226.
28. Gemski P, Lazere JR, Casey T. Plasmid associated with pathogenicity and calcium dependency of Yersinia enterocolitica. Infect Immun 1980; 27:682-685.
29. Portnoy, D. A., Moseley, S. L., Falkow, S. Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun 1981; 31:775-782.
30. Gemski P, Lazere JR, Casey T, et al. Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis. Infect Immun 1980; 28:1044-1047.
31. Ferver DM, Brubaker RR. Plasmids in Yersinia pestis. Infect Immun 1981; 31:839-841.
32. Sodeinde OA, Sample AK, Brubaker RR, et al. Plasminogen activator/ coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun 1988; 56:2749-2752.
33. Bolin I, Wolf WH. Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis. Infect Immun 1984; 43:72-78.
34. Emody L, Heesemann J, Wolf WH, et al. Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol 1989; 171:6674-6679.
35. Isberg RR, Falkow S. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 1985; 317:262-264.
36. Pepe JC, Miller VL. The Yersinia enterocolitica inv gene product is an outer membrane protein that shares epitopes with Yersinia pseudotuberculosis invasin. J Bacteriol 1990; 172:3780-3789.
37. Jerse AE, Yu J, Tall BD, et al. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990; 87:7839-7843.
38. Miller VL. Yersinia invasion genes and their products. ASM News 1992; 58:26-33.
39. Miller VL, Farmer III JJ, Hill WE, et al. The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease. Infect Immun 1989; 57:121-131.
40. Lindler LE, Tall BD. Yersinia pestis pH 6 antigen forms fimbriae and is induced by intracellular association with macrophages. Mol Microbiol 1993; 8:311-324.
41. Rosqvist R, Skurnik M, Wolf WH. Increased virulence of Yersinia pseudotuberculosis by two independent mutations. Nature 1988; 334:522-524.
42. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60:861-871.
43. Tertti R, Skurnik M, Vartio T, et al. Adhesion protein YadA of Yersinia species mediates binding of bacteria to fibronectin. Infect Immun 1992; 60:3021-3024.
44. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994; 180:15-23.
45. Clark MA, Jepson MA, Simmons NL, et al. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Res Microbiol 1994; 145:543-552.
46. Rosqvist R, Forsberg A, Rimpilainen M, et al. The cytotoxic protein YpoE of Yersinia obstructs the primary host defence. Mol Microbiol 1990; 4:657-667.
47. Higuchi K, Smith JL. Studies on the nutrition and physiology of Pasteurella pestis. VI. A differential plating medium for the estimation of the mutation rate to avirulence. J Bacteriol 1961; 81:605-608.
48. Straley SC, Brubaker RR. Cytoplasmic and membrane proteins of yersiniae cultivated under conditions simulating mammalian intracellular environment. Proc Natl Acad Sci USA 1981; 78:1224-1228.
49. Bolin I, Norlander L, Wolf WH. Temperature-inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica is associated with the virulence plasmid. Infect Immun 1982; 37:506-512.
50. Bolin I, Portnoy DA, Wolf WH. Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun 1985; 48:234-240.
51. Rosqvist R, Bolin I, Wolf WH. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect Immun 1988; 56:2139-2143.
52. Rosqvist R, Forsberg A, Wolf WH. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun 1991; 59:4562-4569.
53. Guan K, Dixon JE. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 1990; 249:553-556.
54. Bliska JB, Clemens JC, Dixon JE, et al. The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. J Exp Med 1992; 176:1625-1630.
55. Bliska JB, Guan KL, Dixon JE, et al. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci USA 1991; 88:1187-1191.
56. Bliska JB, Black DS. Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase. Infect Immun 1995; 63:681-685.
57. Fallman M, Andersson K, Hakansson S, et al. Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect Immun 1995; 63:3117-3124.
58. Galyov EE, Hakansson S, Forsberg A, et al. A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 1993; 361:730-732.
59. Leung KY, Straley SC. The yopM gene of Yersinia pestis encodes a released protein having homology with the human platelet surface protein GPIb alpha. J Bacteriol 1989; 171:4623-4632.
60. China B, Sory MP, N'Guyen BT, et al. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect Immun 1991; 61:3129-3136.
61. Holmstrom A, Rosqvist R, Wolf WH, et al. Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice. Infect Immun 1995; 63:2269-2276.
62. Bergman T, Hakansson S, Forsberg A, et al. Analysis of the V antigen IcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J Bacteriol 1991; 173:1607-1616.
63. Motin VL, Nakajima R, Smirnov GB, et al. Passive immunity to yersiniae mediated by antirecombinant V antigen and protein A-V antigen fusion peptide. Infect Immun 1994; 62:4192-4201.
64. 2+ response. Mol Microbiol 1993; 8:1005-10.
65. Cornelis GR. Yersinia, finely tuned pathogens. In: Hormaeche CE, Penn CW, Smyth CJ, eds. Molecular Biology of Bacterial Infections: Current Status and Future Perspectives. Cambridge, UK: Cambridge University Press, 1992:231-265.
66. Cornelis GR, Sluiters C, Lambert-de-Rouvroit C, et al. Homology between virF, the transcriptional activator of the Yersinia virulence region, and AraC, the Escherichia coli arabinose operon regulator. J Bacteriol 1989; 171:254-262.
67. Lambert-de-Rouvroit. C, Sluiters C, Cornelis GR. Role of the transcriptional activator, VirF, and temperature in the expression of the pYV plasmid genes of Yersinia enterocolitica. Mol Microbiol 1992; 6:395-409.
68. Price SB, Straley SC. LcrH, a gene necessary for virulence of Yersinia pestis and the normal response of Y. pestis to ATP and calcium. Infect Immun 1989; 57:1491-1498.
69. Forsberg A, Viitanen AM, Skurnik M, et al. The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol Microbiol 1991; 5:977-986.
70. Rosqvist R, Magnusson KE, Wolf WH. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J 1994; 13:964-972.
71. Michiels T, Vanooteghem Jc, Lambert-de-Rouvroit C, et al. Analysis of virC, an operon involved in the secretion of Yop proteins by Yersinia enterocolitica. J. Bacteriol 1991; 173:4994-5009.
72. Bergman T, Erickson K, Galyov E, et al. The lcrB (yscN/U) gene cluster of Yersinia pseudotuberculosis is involved in Yop secretion and shows high homology to the spa gene clusters of Shigella flexneri and Salmonella typhimurium. J Bacteriol 1994; 176:2619-2626.
73. Allaoui A, Woestyn S, Sluiters C, et al.. YscU, a Yersinia enterocolitica inner membrane protein involved in Yop secretion. J Bacteriol 1994; 176:4534-4542.
74. Wattiau P, Cornelis GR. SycE, a chaperone-like protein of Yersinia enterocolitica involved in Ohe secretion of YopE. Mol Microbiol 1993; 8:123-131.
75. Lindsten EF, Rosqvist R, Johansson L, et al. The chaperon-like protein of Yer A of Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensible for targeting to the secretion loci. Mol Microbiol 1995; 16:635-647.
76. Michiels T, Wattiau P, Brasseur R, et al. Secretion of Yop proteins by yersiniae. Infect Immun 1990; 58:2840-2849.
77. Rosqvist R, Hakansson S, Forsberg A, et al. Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae. EMBO J 1995; 14:4187-4195.
78. Ginocchio CC, Galan JE. Functional conservation among members of the Salmonella typhimurium InvA family of proteins. Infect Immun 1995; 63:729-732.
79. Yoshino K, Abe J, Murata H, et al. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis. FEBS Lett 1994; 356:141-144.
80. Miyoshi AT, Imanishi K, Uchiyama T. Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells. Infect Immun 1993; 61:3922-3927.
81. Blomster-Hautamaa D, Kreiswirth BN, Kornblum JS, et al. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem 1986; 261:15783-15786.
82. Huang IY, Hughes JL, Bergdoll MS, et al. Complete amino acid sequence of staphylococcal enterotoxin A. J Biol Chem 1987; 262:7006-7013.
83. Betley MJ, Mekalanos JJ. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol 1988; 170:34-41.
84. Huang IY, Bergdoll MS. The primary structure of staphylococcal enterotoxin B. J Biol Chem 1970; 245:3518-3525.
85. Jones CL, Khan SA. Nucleotide sequence of the enterotoxin B gene from Stephylococcus aureus. J Bacteriol 1986; 166:29-33.
86. Schmidt JJ, Spero L. The complete amino acid sequence of staphylococcal enterotoxin C1. J Biol Chem 1983; 258:6300-6306.
87. Bohach GA, Schlievert PM. Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol Gen Genet 1987; 209:15-20.
88. Couch JL, Betley MJ. Nucleotide sequence of the type C3 staphylococcal enterotoxin gene suggests that intergenic recombination causes antigenic variation. J Bacteriol 1989; 171:4507-4510.
89. Bayles KW, Iandolo JJ. Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D. J Bacteriol 1989; 171:4799-4806.
90. Couch JL, Soltis MT, Betley MJ. Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene. J Bacteriol 1988; 170:2954-2960.
91. Weeks CR, Ferretto JJ. Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect Immun 1986; 52:144-150.
92. Johnson LP, L'Italien JJ, Schlievert PM. Streptococcal pyrogenic exotoxin A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol Gen Genet 1986; 203:354-356.
93. Goshorn SC, Schlievert PM. Nucleotide sequence of streptococcal pyrogenic exotoxin type C. Infect Immun 1988; 56:2518-2520.
94. Shine J, Dalgarno L. The 3′-terminal sequence of Escherichia coli 16S ribosomal RNA: complementary to nonsense triplets and ribosome binding sites. Proc Natl Acad Sci USA 1974; 71:1342-1346.
95. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acid Res 1986; 14:4683-4690.
96. Lipman DJ, Pearson WR. Rapid and sensitive protein similarity searches. Science 1985; 227:1435-1441.
97. Maina CV, Riggs PD, Grandea III AG, et al. A vector to express and purify foreign proteins in Escherichia coli by fusion to, and separation from, maltose binding protein. Gene 1988; 74:365-373.
98. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-711.
99. Herman A, Croteau G, Sekaly RP, et al. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T Cells. J Exp Med 1990; 172:709-717.
100. Herman A, Kappler JW, Marrack P, et al. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9:745-772.
101. Inoko H, Bodmer JG, Heyes JM, et al. Joint report on the transfectant/ monoclonal antibody component. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA-1991, Vol 1. London: Oxford University Press, 1992:919.
102. Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. J Exp Med 1988; 167:1697-1707.
103. Carlsson R, Fischer H, Sjogren HO. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988; 1401:2484-2488.
104. White J, Herman A, Pullen AM, et al. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56:27-35.
105. Kappler J, Kotzin B, Herron L, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989; 244:811-813.
106. Choi Y, Kotzin B, Herron L, et al. Interaction of S. aureus toxin superantigens with human T cells. Proc Natl Acad Sci USA 1989; 86:8941-8945.
107. Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253:325-329.
108. Abe J, Kotzin BL, Meissner C, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Ex Med 1993; 177:791-796.
109. Tsubokura MK, Otsuki K, Sato M, et al. Special features of distribution of Yersinia pseudotuberculosis in Japan. J Clin Microbiol 1989; 27:790-791.
110. Carniel E, Mollarat HH. Yersiniosis. Comp Immun Microbiol Infect Dis 1990; 13:51-58.
111. Sato K, Ouchi K, Taki M. Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr Infect Dis 1983; 2:123-126.
112. Inoue M, Nakashima H, Ueba O, et al. Community outbreak of Yersinia pseudotuberculosis. Contrib Microbiol Immunol 1984; 28:883-891.
113. Somov GP, Martinevsky IL. New facts about pseudotuberculosis in the USSR. Contrib Microbiol Immunol 1973; 2:214-216.
114. Takeda N, Usami I, Fujita A, et al. Renal complications of Yersinia pseudotuberculosis infection in children. Contrib Microbiol Immunol 1991; 12:301-306.
115. Takeda N, Konishi N, Nishida Y. [Similarites of clinical symptoms between Kawasaki disease and infection by Yersinia pseudotuberculosis]. (in Japanese) Shounikashinryou 1996; 59:47-53.
116. Bohach GA, Fast DJ, Nelson RD, et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-272.
117. Kotzin BL, Leung DY, Kappler J, et al. Superantige and their potential role in human disease. Adv Immunol 1993; 54:99-166.
118. Miethke T, Wahl C, Regele D, et al. Superantigen mediated shock: a cytokine release syndrome. Immunobiology 1993; 189:270-284.
119. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8:411-426.
120. Parsonnet J, Gillis ZA, Richter GA, et al. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun 1987; 55:1070-1076.
121. Miethke T, Wahl C, Heeg K, et al. T-cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992; 175:91-98.
122. Miethke T, Duschek K, Wahl C, et al. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol 1993; 23:1494-1500.
123. Choi Y, Lafferty JA, Clements JR, et al. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 1990; 172:981-984.
124. Abe, J., Ito, Y., Yoshino, K. et al. Genetic analysis of a novel superantigen produced by Yersinia pseudotuberculosis and its effect in acute phase patients. Experimental Biology 95, Atlanta, GA, April 9-13, 1995.
125. Autenrieth IB, Beer M, Bohn E, et al. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistance C57BL/6 mice: an essential role for gamma interferon. Infect Immun 1994; 62:2590-2599.
126. Autenrieth IB, Vogel U, Preger S, et al. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparsion of time course, histomorphology, and immune response. Infect Immun 1993; 61:2585-95.
127. Noll A, Roggenkamp A, Heesemann J, et al. Protective role for heat shock protein-reactive αβ T cells in murine yersiniosis. Infect Immun 1994; 62:2784-2791.
128. Starnbach MN, Bevan MJ. Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J Immunol 1994; 153:1603-1612.
129. Kousa M, Lassus A, Karvonen J, et al. Family study of Reiter's disease and HLA B27 distribution. J Rheumatol 1977; 4:95-102.
130. Dequeker J, Decock T, Walravens M, et al. A systematic study of the HLA B27 prevalence in inflammatory rheumatic diseases. J Rheumatol 1978; 5:452-459.
131. Capron JP, Delammarre J, Delcenserie R, et al. Liver abscess complicating Yersinia pseudotuberculosis ileitis. Gastroenterology 1981; 81:150-152.
132. Blaser MJ, Miller RA, Lacher J, et al. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984; 87:888-894.
133. Treacher DF, Jewell DP. Yersinia colitis associated with Crohn's disease. Postgrad Med J 1985; 61:173-174.
134. Iijima K, Yoshikawa N, Sato K, et al. Acute interstitial nephritis associated with Yersinia pseudotuberculosis infection. Am J Nephrol 1989; 9:236-240.
135. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: clinical observation of 50 cases. Jpn J Allergy 1967; 16:178-222.
136. Yanagisawa M, Kobayashi N, Matsuya S. Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MCLS) in an infant. Pediatrics 1974; 54:277-281.
137. Ouchi K. [Kawasaki disease and yersiniosis] (in Japanese). Shouninaika 1985; 17:745-749.
138. Larsen JH. Kawasaki disease, a yersiniosis? J Infect Dis 1989; 160:900-901.
139. Konishi N, Maruko T, Waki K, et al. A clinical investigation of Kawasaki disease documented with Yersinia pseudotuberculosis infection. In: Kato H, ed. Kawasaki Disease. Amsterdam, The Netherlands: Elsevier Science, 1995:241-247.
140. Leung DY, Meissner HC, Fulton DR, et al. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342:1385-1388.
141. Takeda T, Abe J, Yoshino K, et al. Establishment of a novel superantigen produced by Yersinia pseudotuberculosis and its association with systemic Kawasaki disease-like symptoms. In: Kato H, ed. Kawasaki Disease. Amsterdam, The Netherlands: Elsevier Science, 1995:193-199.
142. Valtonen V, Leirisalo M, Pentikainen PJ, et al. Triggering infections in reactive arthritis. Ann Rheum Dis 1985; 44:399-405.
143. Chen JH, Kono DH, Yong Z, et al. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol 1987; 139:3003-3011.
144. Zhang JJ, Hamachi M, Hamachi T, et al. The bacterial outer membrane protein that reacts with anti-HLA-B27 antibodies is the OmpA protein. J Immunol 1989; 143:2955-2960.
145. Tsuchiya N, Husby G, Williams RJ. Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis. Clin Exp Immunol 1990; 82:493-498.
146. Kono DH, Park MS, Yu DT, et al. Absence of lymphotoxic antibodies in patients with Yersinia-induced arthritis, Reiter's syndrome and ankylosing spondylitis. Clin Exp Rheum 1984; 2:303-307.
147. Inman RD, Chiu B, Johnston ME, et al. Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships. Immunology 1986; 58:501-506.
148. Kapasi K, Chui B, Inman RD. HLA-B27/microbial mimicry; an in vivo analysis. Immunology 1992; 77:456-461.
149. Granfors K, Jalkanen S, Von Essen R, et al. Yersinia antigens in synovial fluid cells from patients with ReA. N Engl J Med 1989; 320:216-221.
150. Hammer M, Zeidler H, Klimsa S, et al. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum 1990; 33:1795-1801.
151. Gaston JS, Life PF, Granfors K, et al. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol 1989; 76:348-353.
152. Hermann E, Fleischer B, Mayet WJ, et al. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis. Clin Exp Immunol 1989; 75:365-370.
153. Life PF, Viner NJ, Bacon PA, et al. Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis. Clin Exp Immunol 1990; 79:189-194.
154. Hermann E, Lohse AW, Van dZR, et al. Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol 1991; 21:2139-2143.
155. Lahesmaa R, Yssel H, Batsford S, et al. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol 1992; 148:3079-3085.
156. Probst P, Hermann E, Meyer zBK, et al. Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect immun 1993; 61:4507-4509.
157. Probst P, Hermann E, Meyer zBK, et al. Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen. J Infect Dis 1993; 167:385-391.
158. Hermann E, Yu DT, Meyer zBK, et al. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342:646-650.
159. Hill JL, Yu DT. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun 1987; 55:721-726